Kip Piper's Health Care Blog
Medicare, Medicaid, Health Reform

Federal health agencies, like the Centers for Medicare and Medicaid Services and the Food and Drug Administration, must maintain large congressional liaison offices. Below is a listing of congressional liaison offices of federal health agencies, including CMS, FDA, CDC, AHRQ, and NIH, as well as shops like OMB and CBO that have...
Sellers Dorsey announced key leadership changes aimed at business expansion at its annual meeting on October 23. Harvey Hurdle became the Chief Executive Officer and Sellers Dorsey's founder and current Chief Executive Officer, Martin Sellers, will now serve as Founder and Chairman. "I am honored to lead Sellers Dorsey and...
Are you ready to be an Accountable Care Organization (ACO)? Significant new opportunities and challenges face health systems, hospitals, and physician practices as they decide whether to participate in the new Medicare Shared Savings Program and join together to form an Accountable Care Organization. Accountable Care Organizations: Your Guide to Strategy, Design, and Implementation is...
It's always fascinating and often amusing to watch the partisan spin masters and media talking heads following an election. Some practice spin like it was high art, suitable for framing in the Louvre. But with a 24-hour news cycle to fill, many are about as sophisticated as a reality...
The Accountable Care Organization (ACO) model is a new Medicare option for physicians, hospitals, and other providers to share in cost-savings. ACOs represent a dramatic change in Medicare policy and an opportunity to transform care delivery and provider alignment. The Medicare Gain Sharing Program, part of the newly enacted healthcare...
Under the Patient Protection and Affordable Care Act (PPACA) of 2010, Medicare providers, including physician groups and hospitals, will soon have the option to form Accountable Care Organizations (ACOs) to improve quality and efficiency. ACO providers may share financial gains generated from improved clinical and economic performance, provided that quality...
The latest issue of the journal American Health & Drug Benefits includes a valuable mix of studies and articles of interest to decision makers. Topics include health reform, bundled payment, drug pricing, benefit design, Medicaid, medication therapy, and specific clinical conditions. The Health Reform Law: Key Changes to Be Implemented...
Federally mandated rebates for prescription drugs in Medicaid were expanded significantly - by $38 billion - under the new health reform law, with extraordinary financial, administrative, and compliance implications for pharmaceutical manufacturers, Medicaid health plans, and state Medicaid programs. In a new journal article, I explain changes to the Medicaid...
Please join American Health & Drug Benefits in Philadelphia on May 21, 2010 for The Patient Priority: Achieving Pharmaceutical Success in a Fractionated, Multi-Stakeholder Healthcare Environment. The program will help identify clinical, business, and policy governing dynamics and tactics for patient-centered drug development and commercial success. A dinner reception will follow...
The latest issue of the journal American Health & Drug Benefits includes a valuable mix of studies and articles on economic, regulatory, and clinical issues of particular interest to payors, purchasers, and policymakers. Obesity: Effective Treatment Requires Change in Payers' Perspective by Rhonda Greenapple, MSPH and Jackie Ngai, MS, with...

Stay Connected

4,688FansLike
6,936FollowersFollow
21,503FollowersFollow

Latest Articles